Mauna Kea Technologies SAS (ALMKT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.077x

Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has a cash flow conversion efficiency ratio of 0.077x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.28 Million ≈ $-2.67 Million USD) by net assets (€-29.42 Million ≈ $-34.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALMKT net asset quality score to measure how much of total assets are equity-financed.

Mauna Kea Technologies SAS - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Mauna Kea Technologies SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ALMKT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Mauna Kea Technologies SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mauna Kea Technologies SAS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Synel M.L.L Payway Ltd
TA:SNEL
0.021x
Metallic Minerals Corp
V:MMG
-0.327x
Kincora Copper Ltd
V:KCC
-0.005x
Nable Communications Inc
KQ:153460
-0.018x
D P Wires Limited
NSE:DPWIRES
0.208x
Sunson Textile Manufacturer
JK:SSTM
0.006x
Netgem SA
PA:ALNTG
0.054x
Dimension Computer Technology Co Ltd
TWO:6140
0.186x

Annual Cash Flow Conversion Efficiency for Mauna Kea Technologies SAS (2010–2024)

The table below shows the annual cash flow conversion efficiency of Mauna Kea Technologies SAS from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see ALMKT stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-24.39 Million
≈ $-28.51 Million
€-6.32 Million
≈ $-7.39 Million
0.259x +494.90%
2023-12-31 €-17.28 Million
≈ $-20.20 Million
€-753.00K
≈ $-880.34K
0.044x -90.16%
2022-12-31 €-19.93 Million
≈ $-23.29 Million
€-8.83 Million
≈ $-10.32 Million
0.443x -55.43%
2021-12-31 €-10.33 Million
≈ $-12.08 Million
€-10.27 Million
≈ $-12.01 Million
0.994x +50.29%
2020-12-31 €-12.08 Million
≈ $-14.12 Million
€-7.99 Million
≈ $-9.34 Million
0.662x +101.63%
2019-12-31 €253.00K
≈ $295.78K
€-10.27 Million
≈ $-12.01 Million
-40.601x -2872.05%
2018-12-31 €7.98 Million
≈ $9.33 Million
€-10.90 Million
≈ $-12.74 Million
-1.366x -134.80%
2017-12-31 €16.74 Million
≈ $19.58 Million
€-9.74 Million
≈ $-11.39 Million
-0.582x +17.16%
2016-12-31 €11.16 Million
≈ $13.04 Million
€-7.84 Million
≈ $-9.16 Million
-0.702x +15.62%
2015-12-31 €14.09 Million
≈ $16.47 Million
€-11.73 Million
≈ $-13.71 Million
-0.832x -18.67%
2014-12-31 €18.15 Million
≈ $21.22 Million
€-12.73 Million
≈ $-14.88 Million
-0.701x -120.08%
2013-12-31 €30.16 Million
≈ $35.26 Million
€-9.61 Million
≈ $-11.24 Million
-0.319x +3.61%
2012-12-31 €40.16 Million
≈ $46.95 Million
€-13.28 Million
≈ $-15.53 Million
-0.331x -176.02%
2011-12-31 €51.57 Million
≈ $60.30 Million
€-6.18 Million
≈ $-7.22 Million
-0.120x +67.12%
2010-12-31 €6.86 Million
≈ $8.02 Million
€-2.50 Million
≈ $-2.92 Million
-0.364x --

About Mauna Kea Technologies SAS

PA:ALMKT France Medical Devices
Market Cap
$34.81 Million
€29.78 Million EUR
Market Cap Rank
#23917 Global
#382 in France
Share Price
€0.16
Change (1 day)
+0.65%
52-Week Range
€0.07 - €0.22
All Time High
€5.37
About

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more